SLC16A1 and hepatocellular carcinoma: Moreover, by activating the JAK-STAT3 signaling pathway, IL-6 promoted the glycolysis level and increased the expression of SLC16A1-AS1 in HCC cells, thereby forming a positive feedback loop.